OR

Origin

Active

AI for safer cell & gene therapies

origin.bioSan Francisco, CA, USA

Designing novel regulatory DNA (e.g., enhancers and promoters) to program precise therapeutic gene expression patterns - for diseases like cancer, CNS disorders and more. We're building the largest proprietary dataset of synthetic regulatory sequences across diverse cell-states.

Tags

AIB2BBiotechDataDiagnosticsDrug DiscoveryGenomicsHealthcareMachine LearningSaaS

Investors

Y Combinatoraccelerator

accelerator · 2026

Source
Origin — AI for safer cell & gene therapies | Questd